Sprays, pills, creams oh, aah, ouch! is that familiar? You are not alone. The instant remedy to the strain in a muscle or the headache is now a routine practice in lives of millions of Indians. This has resulted in an explosion of growth in the country in the post-pandemic period as the pain relief market jumps to close to 16,000 crores reaching its doubling point in five years. In India, the treatment of pain is evolving (and quickly) with over-the-counter (OTC) gels and sprays to the household references of Dolo, Zerodol, and Saridon.
💊 Pain Relief Becomes a Daily Dose
The use of pain relief medications is no longer limited to occasional discomfort. With more people hitting the gym, taking up active lifestyles, or suffering from sedentary work-related aches, pain relief products have become as common as toothpaste in Indian households. Gels and sprays for instant relief, creams for long-term care, and pills for quick pain management — consumers are relying on them for everything from neck stiffness and migraines to chronic body aches caused by stress and fatigue.
Data shows that India’s pain management category has added more than a billion dollars in value in the last five years alone. This makes it the largest category within the non-prescription pharma segment, with an astounding 1,552 pain-related brands — including heavy-hitters like Volini, Moov, Omnigel, and Dolo — competing for shelf space.
📈 What’s Driving the Growth?
There are a few key reasons behind this massive growth:
-
Post-pandemic health awareness: The COVID-19 pandemic made consumers more health-conscious and encouraged them to stock up on pain relief essentials.
-
Lifestyle changes: Whether it’s from prolonged work-from-home setups or increased fitness activities, pain from bad posture and exertion has become widespread.
-
OTC availability: Pain relief products are widely available at pharmacies and even grocery stores, increasing accessibility and impulse purchases.
-
Marketing & Brand Trust: Known brands like Dolo and Volini have built significant consumer trust, making their products go-to solutions.
🚨 The Risk of Self-Medication
Although the growth of pain relief market can be considered significant, it has some critical concerns. There is an increased caution among medical professionals of unregulated use of OTC painkillers and topical products. Without professional advice, regular use of the drug may cause side effects, drug tolerance and indications of any underlying problems being suppressed.
Taking a pill is an innocent gesture, however, constant taking of Non-Steroidal Anti-Inflammatory Drugs, such as Dolo or Zerodol, can cause gastric ulcers, kidney diseases and even heart problems. On the same note, topical sprays and creams may irritate the skin by being overused or abused.
In countries such as India where the majority of people self-medicate and OTC requirements are scarcely policied, this is a health issue to the population.
💼 Business Opportunities in the Pain Relief Segment
Despite the health warnings, the business opportunity in India’s pain relief space is massive. New entrepreneurs and pharma professionals are seeing great success by tapping into this growing segment through models like franchise partnerships and contract manufacturing.
If you’re looking to step into the pharma business, associating with a top pharma franchise company in India offers you the benefits of working with a trusted brand while operating independently. These companies offer ready-to-distribute products, monopoly rights, marketing support, and logistical assistance.
Another model gaining traction is the monopoly franchise model, where distributors are given exclusive rights to sell within a particular territory. This not only reduces competition but also increases profitability. You can explore options with a reputable monopoly medicine company in India to capitalize on this strategy.
🧴 Rise in Product Variants
India’s pain relief market is not just growing in value — it’s also diversifying in product offerings. From herbal sprays to Ayurvedic oils, from fast-absorbing creams to cooling gels, every product is tailored to specific demographics and needs. Innovative packaging, long-lasting formulations, and combo packs are becoming common as brands fight for consumer attention.
With nearly five new brands launching every week since the pandemic, the competition is fierce — but so is the demand.
🧠 Educating the Consumer
With the growth of the market there is an increasing demand to educate the consumer on responsible usage. Businesses which make their investments in awareness campaigns and safety messages are not only able to create the credibility of their brand but also contribute to the development of a more informed market.
This is vital in OTC pain relief products whereby the consumer may not read labels or instructions. An educated customer is a safe, courteous user who is also, loyal.
📝 Conclusion
India’s pain relief market has transformed dramatically in the past five years — from a convenience category to a healthcare essential. As it races towards ₹16,000 crore in size, the blend of lifestyle demands, OTC accessibility, and brand trust continues to fuel its momentum.
Whether you’re a healthcare professional, distributor, or aspiring entrepreneur, now is the right time to explore opportunities in this booming segment. By partnering with a top pharma franchise company in India, leveraging a monopoly medicine company in India, or outsourcing to a reliable pharma contract manufacturing company, you can position yourself at the forefront of India’s pain relief revolution.